Identification of Novel Quinolin-2(1H)-ones as Phosphodiesterase 1 Inhibitors for the Treatment of Inflammatory Bowel Disease

被引：8

作者：

Zhang, Bei ^{[1
]}

Yang, Yi-Yi ^{[1
]}

Zhao, Zheng-Jiong ^{[1
]}

Liu, Run-Duo ^{[1
]}

Feng, Ling-Ling ^{[1
]}

Jiang, Mei-Yan ^{[1
]}

Yuan, Yijun ^{[2
]}

Huang, Shuheng ^{[2
]}

Li, Zhe ^{[1
]}

Wang, Quan ^{[1
]}

Luo, Hai-Bin ^{[1
,2
,3
]}

Wu, Yinuo ^{[1
]}

机构：

[1] Sun Yat Sen Univ, Sch Pharmaceut Sci, Guangzhou 510006, Peoples R China

[2] Hainan Univ, Sch Life & Pharmaceut Sci, Key Lab Trop Biol Resources, Minist Educ, Haikou 570228, Hainan, Peoples R China

[3] Hainan Univ, Sch Pharmaceut Sci, Song Li Academician Workstat, Sanya 572000, Peoples R China

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2023年 / 66卷 / 17期

关键词：

DISCOVERY;

D O I：

10.1021/acs.jmedchem.3c01044

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Phosphodiesterase 1 (PDE1) is a subfamily of PDE superenzyme familiesthat can hydrolyze cyclic adenosine monophosphate and cyclic guanosinemonophosphate simultaneously. Currently, the number of PDE1 inhibitorsis relatively few, significantly limiting their application. Herein,a novel series of quinolin-2(1H)-ones were designedrationally, leading to compound 10c with an IC50 of 15 nM against PDE1C, high selectivity across other PDEs, andremarkable safety properties. Furthermore, we used the lead compound 10c as a chemical tool to explore whether PDE1 could workas a novel potential target for the treatment of inflammatory boweldisease (IBD), a disease which is a chronic, relapsing disorder ofthe gastrointestinal tract inflammation lacking effective treatment.Our results showed that administration of 10c exertedsignificant anti-IBD effects in the dextran sodium sulfate-inducedmice model and alleviated the inflammatory response, indicating thatPDE1 could work as a potent target for IBD.

引用

页码：12468 / 12478

页数：11

共 50 条

[41] Identification of 2(1H)-pyrimidinones as potential EGFR T790M inhibitors for the treatment of gefitinib-resistant non-small cell lung cancer [J].

Huang, Jianping ;

Huang, Jiaxin ;

Wang, Ning ;

Wan, Luhong ;

Li, Lei ;

Wang, Changyuan ;

Sun, Xiuli ;

Li, Yongming ;

Huang, Guoping ;

Ma, Xiaodong .

BIOORGANIC CHEMISTRY, 2019, 89

[42] Identification of 4-phenylquinolin-2(1H)-one as a specific allosteric inhibitor of Akt [J].

Huang, Bill X. ;

Newcomer, Kenny ;

Kevala, Karl ;

Barnaeva, Elena ;

Zheng, Wei ;

Hu, Xin ;

Patnaik, Samarjit ;

Southall, Noel ;

Marugan, Juan ;

Ferrer, Marc ;

Kim, Hee-Yong .

SCIENTIFIC REPORTS, 2017, 7

[43] Identification of novel 7-amino-5-methyl-1,6-naphthyridin-2(1H)-one derivatives as potent PI3K/mTOR dual inhibitors [J].

Lin, Songwen ;

Han, Fangbin ;

Liu, Peng ;

Tao, Jing ;

Zhong, Xuechao ;

Liu, Xiujie ;

Yi, Chongqin ;

Xu, Heng .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (03) :790-793

[44] Copper-Catalyzed Direct Carbamoylation of Quinoxalin-2(1H)-ones with Hydrazinecarboxamides Under Mild Conditions [J].

Chu, Xianglong ;

Wu, Yujuan ;

Lu, Haigen ;

Yang, Bingchuan ;

Ma, Chen .

EUROPEAN JOURNAL OF ORGANIC CHEMISTRY, 2020, 2020 (09) :1141-1144

[45] Targeted Synthesis of Complex Spiro[3H-indole-3,2′-pyrrolidin]-2(1H)-ones by Intramolecular Cyclization of Azomethine Ylides: Highly Potent MDM2-p53 Inhibitors [J].

Gollner, Andreas ;

Weinstabl, Harald ;

Fuchs, Julian E. ;

Rudolph, Dorothea ;

Garavel, Geraldine ;

Hofbauer, Karin S. ;

Karolyi-Oezguer, Jale ;

Gmaschitz, Gerhard ;

Hela, Wolfgang ;

Kerres, Nina ;

Grondal, Elisabeth ;

Werni, Patrick ;

Ramharter, Juergen ;

Broeker, Joachim ;

McConnell, Darryl B. .

CHEMMEDCHEM, 2019, 14 (01) :88-93

[46] Design, synthesis and inhibitory activity of novel 2, 3-dihydroquinolin-4(1H)-one derivatives as potential succinate dehydrogenase inhibitors [J].

Cheng, Wei ;

Yan, Yingkun ;

Xiao, Tingting ;

Zhang, Guilan ;

Zhang, Tingting ;

Lu, Tong ;

Jiang, Wenjing ;

Wang, Jingwen ;

Tang, Xiaorong .

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 214

[47] Synthesis and biological evaluation of novel 1,6-diaryl pyridin-2(1H)-one analogs [J].

Chen, Taijie ;

Luo, Yu ;

Hu, Youhong ;

Yang, Bo ;

Lu, Wei .

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2013, 64 :613-620

[48] Identification of Novel Mutant (R132H) Isocitrate Dehydrogenase 1 Inhibitors for Glioma Therapy [J].

Murali, Poornimaa ;

Karuppasamy, Ramanathan .

JOURNAL OF COMPUTATIONAL BIOPHYSICS AND CHEMISTRY, 2022, 21 (06) :647-661

[49] Structure-guided optimization of 4,6-substituted-1,3,5-triazin-2(1H)-ones as catalytic inhibitors of human DNA topoisomerase IIα [J].

Bergant, Kaja ;

Janezic, Matej ;

Valjavec, Katja ;

Sosic, Izidor ;

Pajk, Stane ;

Stampar, Martina ;

Zegura, Bojana ;

Gobec, Stanislav ;

Filipic, Metka ;

Perdih, Andrej .

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 175 :330-348

[50] Identification and Development of 2,3-Dihydropyrrolo[1,2-a]quinazolin-5(1H)-one Inhibitors Targeting Bromodomains within the Switch/Sucrose Nonfermenting Complex [J].

Sutherell, Charlotte L. ;

Tallant, Cynthia ;

Monteiro, Octovia P. ;

Yapp, Clarence ;

Fuchs, Julian E. ;

Fedorov, Oleg ;

Siejka, Paulina ;

Muller, Suzanne ;

Knapp, Stefan ;

Brenton, James D. ;

Brennan, Paul E. ;

Ley, Steven V. .

JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (10) :5095-5101

← 1 2 3 4 5 →